Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
61-68
Author(s):
M. Frier
Safety and Utilization of Blood Components as Therapeutic Delivery Systems
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
275-282
Author(s):
Tiffany Adams, Fars Alanazi and D. Robert Lu
Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2113-2130
Author(s):
Yoshisuke Nishi
Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1889-1903
Author(s):
Clair S. Gricks and John G. Gribben
Gene Therapy of Cancer with Interleukin-12
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1981-1991
Author(s):
Guillermo Mazzolini, Jesus Prieto and Ignacio Melero
Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Journal:
Current Pharmacogenomics
Volume:
1
Page:
175-186
Author(s):
Jang-Ming Lee, Yung-Chie Lee, Chien-Jen Chen and Ming-Tsang Wu
Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
221-238
Author(s):
Christine A. White
Observations on the Use of the Avian Chorioallantoic Membrane (CAM) Model in Investigations into Angiogenesis
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
3
Page:
155-185
Author(s):
Mary Richardson and Gurmit Singh
Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
115-128
Author(s):
Yoshiyasu Aoki and Giovanna Tosato
Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
137-149
Author(s):
V. Sharma